C-Jun and Ets2 proteins regulate expression of spleen tyrosine kinase in T cells

Journal of Biological Chemistry

Volumn 287, Issue 15, 2012, Pages 11833-11841

  Ghosh, Debjani ^a   Tsokos, George C ^a   Kyttaris, Vasileios C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADDITIVE EFFECTS; B CELLS; BASAL PROMOTER; CALCIUM FLUX; CALCIUM RESPONSE; CLOSE PROXIMITY; OVER-EXPRESSION; PROMOTER ACTIVITIES; SIMILAR PATTERN; SPLEEN TYROSINE KINASE; SYSTEMIC LUPUS ERYTHEMATOSUS; T CELLS; T-CELL RECEPTORS;

AMINO ACIDS; CELL MEMBRANES; ENZYMES; PHOSPHORYLATION; TRANSCRIPTION FACTORS;

CYTOLOGY;

PROTEIN C JUN; PROTEIN KINASE SYK; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR ETS 2;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CALCIUM TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

ADULT; B-LYMPHOCYTES; BASE SEQUENCE; BINDING SITES; CALCIUM SIGNALING; CELLS, CULTURED; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEIN C-ETS-2; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC;

EID: 84859496039     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.333997     Document Type: Article

References (19)

1. Krishnan, S., Juang, Y. T., Chowdhury, B., Magilavy, A., Fisher, C. U., Nguyen, H., Nambiar, M. P., Kyttaris, V., Weinstein, A., Bahjat, R., Pine, P., Rus, V., and Tsokos, G. C. (2008) Differential expression and molecular associations of Syk in systemic lupus erythematosus T cells. J. Immunol. 181, 8145-8152
2. Krishnan, S., Warke, V. G., Nambiar, M. P., Tsokos, G. C., and Farber, D. L. (2003) The FcR γ-subunit and Syk kinase replace the CD3 ζ-chain and ZAP-70 kinase in the TCR signaling complex of human effector CD4 T cells. J. Immunol. 170, 4189-4195 (Pubitemid 36428184)
3. Bahjat, F. R., Pine, P. R., Reitsma, A., Cassafer, G., Baluom, M., Grillo, S., Chang, B., Zhao, F. F., Payan, D. G., Grossbard, E. B., and Daikh, D. I. (2008) An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus. Arthritis Rheum. 58, 1433-1444 (Pubitemid 351705932)
4. Deng, G. M., Liu, L., Bahjat, F. R., Pine, P. R., and Tsokos, G. C. (2010) Suppression of skin and kidney disease by inhibition of spleen tyrosine kinase in lupus-prone mice. Arthritis Rheum. 62, 2086-2092
5. Weinblatt, M. E., Kavanaugh, A., Burgos-Vargas, R., Dikranian, A. H., Medrano-Ramirez, G., Morales-Torres, J. L., Murphy, F. T., Musser, T. K., Straniero, N., Vicente-Gonzales, A. V., and Grossbard, E. (2008) Treatment of rheumatoid arthritis with a Syk kinase inhibitor: a twelve-week, randomized, placebo-controlled trial. Arthritis Rheum. 58, 3309-3318
6. Ghosh, D., Kis-Toth, K., Juang, Y. T., and Tsokos, G. C. (2012) CREM-αsuppresses spleen tyrosine kinase expression in normal but not systemic lupus erythematosus T cells. Arthritis Rheum. 64, 799-807
7. Hochberg, M. C. (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 40, 1725
8. Bombardier, C., Gladman, D. D., Urowitz, M. B., Caron, D., and Chang, C. H. (1992) Derivation of the SLEDAI: a disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 35, 630-640
9. Cross, J. C., Wen, P., and Rutter, W. J. (1993) Transactivation by hepatitis B virus X protein is promiscuous and dependent on mitogen-activated cellular serine/threonine kinases. Proc. Natl. Acad. Sci. U.S.A. 90, 8078-8082 (Pubitemid 23260858)
10. Yang, B. S., Hauser, C. A., Henkel, G., Colman, M. S., Van Beveren, C., Stacey, K. J., Hume, D. A., Maki, R. A., and Ostrowski, M. C. (1996) Rasmediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2. Mol. Cell. Biol. 16, 538-547 (Pubitemid 26029092)
11. Manna, P. R., Eubank, D. W., Lalli, E., Sassone-Corsi, P., and Stocco, D. M. (2003) Transcriptional regulation of the mouse steroidogenic acute regulatory protein gene by the cAMP-response element-binding protein and steroidogenic factor 1. J. Mol. Endocrinol. 30, 381-397 (Pubitemid 36722626)
12. Manna, P. R., Eubank, D. W., and Stocco, D. M. (2004) Assessment of the role of activator protein-1 on transcription of the mouse steroidogenic acute regulatory protein gene. Mol. Endocrinol. 18, 558-573 (Pubitemid 38328203)
13. Dignam, J. D., Lebovitz, R. M., and Roeder, R. G. (1983) Accurate transcription initiation byRNApolymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11, 1475-1489
14. Nambiar, M. P., Fisher, C. U., Warke, V. G., Krishnan, S., Mitchell, J. P., Delaney, N., and Tsokos, G. C. (2003) Reconstitution of deficient T cell receptor ζ-chain restores T cell signaling and augments T cell receptor/ CD3-induced interleukin-2 production in patients with systemic lupus erythematosus. Arthritis Rheum. 48, 1948-1955 (Pubitemid 36828690)
15. Manning, A. M., and Davis, R. J. (2003) Targeting JNK for therapeutic benefit: from junk to gold? Nat. Rev. Drug Discov. 2, 554-565 (Pubitemid 37361747)
16. Rozek, D., and Pfeifer, G. P. (1993) In vivo protein-DNA interactions at the c-jun promoter: preformed complexes mediate the UV response. Mol. Cell. Biol. 13, 5490-5499 (Pubitemid 23260652)
17. Molad, Y., Amit-Vasina, M., Bloch, O., Yona, E., and Rapoport, M. J. (2010) Increased ERK and JNK activities correlate with disease activity in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 69, 175-180
18. Adler, V., Schaffer, A., Kim, J., Dolan, L., and Ronai, Z. (1995) UV irradiation and heat shock mediate JNK activation via alternate pathways. J. Biol. Chem. 270, 26071-26077
19. Dong, C., Yang, D. D., Tournier, C., Whitmarsh, A. J., Xu, J., Davis, R. J., and Flavell, R. A. (2000) JNK is required for effector T cell function but not for T cell activation. Nature 405, 91-94 (Pubitemid 30321821)